123 related articles for article (PubMed ID: 37793560)
41. Topical treatment with the bacterium-derived c-Met agonist InlB
Chalenko YM; Sysolyatina EV; Sobyanin KA; Kapkaeva MR; Lavrikova A; Kalinin E; Scheglovitova ON; Ermolaeva SA
Arch Dermatol Res; 2018 Dec; 310(10):849-856. PubMed ID: 30306262
[TBL] [Abstract][Full Text] [Related]
42. State of the structure address on MET receptor activation by HGF.
Linossi EM; Estevam GO; Oshima M; Fraser JS; Collisson EA; Jura N
Biochem Soc Trans; 2021 Apr; 49(2):645-661. PubMed ID: 33860789
[TBL] [Abstract][Full Text] [Related]
43. Impaired ligand-dependent MET activation caused by an extracellular SEMA domain missense mutation in lung cancer.
Miao W; Sakai K; Sato H; Imamura R; Jangphattananont N; Takagi J; Nishita M; Minami Y; Matsumoto K
Cancer Sci; 2019 Oct; 110(10):3340-3349. PubMed ID: 31342590
[TBL] [Abstract][Full Text] [Related]
44. Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins.
Hasenauer S; Malinger D; Koschut D; Pace G; Matzke A; von Au A; Orian-Rousseau V
PLoS One; 2013; 8(4):e62357. PubMed ID: 23626807
[TBL] [Abstract][Full Text] [Related]
45. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes.
Braun L; Ghebrehiwet B; Cossart P
EMBO J; 2000 Apr; 19(7):1458-66. PubMed ID: 10747014
[TBL] [Abstract][Full Text] [Related]
46. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
[TBL] [Abstract][Full Text] [Related]
47. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
48. The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization.
Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
Eur J Histochem; 2010 Jun; 54(2):e24. PubMed ID: 20558345
[TBL] [Abstract][Full Text] [Related]
49. Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
Gherardi E; Sandin S; Petoukhov MV; Finch J; Youles ME; Ofverstedt LG; Miguel RN; Blundell TL; Vande Woude GF; Skoglund U; Svergun DI
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4046-51. PubMed ID: 16537482
[TBL] [Abstract][Full Text] [Related]
50. A role for host cell exocytosis in InlB-mediated internalisation of Listeria monocytogenes.
Van Ngo H; Bhalla M; Chen DY; Ireton K
Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28745416
[TBL] [Abstract][Full Text] [Related]
51. Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells.
Veiga E; Cossart P
Nat Cell Biol; 2005 Sep; 7(9):894-900. PubMed ID: 16113677
[TBL] [Abstract][Full Text] [Related]
52. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.
Xiao GH; Jeffers M; Bellacosa A; Mitsuuchi Y; Vande Woude GF; Testa JR
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):247-52. PubMed ID: 11134526
[TBL] [Abstract][Full Text] [Related]
53. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.
Kirchhofer D; Yao X; Peek M; Eigenbrot C; Lipari MT; Billeci KL; Maun HR; Moran P; Santell L; Wiesmann C; Lazarus RA
J Biol Chem; 2004 Sep; 279(38):39915-24. PubMed ID: 15218027
[TBL] [Abstract][Full Text] [Related]
54. Host Serine/Threonine Kinases mTOR and Protein Kinase C-α Promote InlB-Mediated Entry of Listeria monocytogenes.
Bhalla M; Law D; Dowd GC; Ireton K
Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28461391
[TBL] [Abstract][Full Text] [Related]
55. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis.
Tremmel M; Matzke A; Albrecht I; Laib AM; Olaku V; Ballmer-Hofer K; Christofori G; Héroult M; Augustin HG; Ponta H; Orian-Rousseau V
Blood; 2009 Dec; 114(25):5236-44. PubMed ID: 19773544
[TBL] [Abstract][Full Text] [Related]
56. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
57. The Host Scaffolding Protein Filamin A and the Exocyst Complex Control Exocytosis during InlB-Mediated Entry of
Bhalla M; Van Ngo H; Gyanwali GC; Ireton K
Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30348826
[No Abstract] [Full Text] [Related]
58. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
59. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
[TBL] [Abstract][Full Text] [Related]
60. Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity.
McCall-Culbreath KD; Li Z; Zutter MM
Blood; 2008 Apr; 111(7):3562-70. PubMed ID: 18198349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
